Literature DB >> 12239324

Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs.

Dusan Cmarko1, Stig-Ove Bøe, Catia Scassellati, Anne Marie Szilvay, Svend Davanger, Xiang-Dong Fu, Gunnar Haukenes, Karl-Henning Kalland, Stanislav Fakan.   

Abstract

To define the human immunodeficiency virus type 1 (HIV-1) RNA maturation pathways, we analyzed the intracellular distribution of HIV-1 RNA and the viral regulatory proteins Rev and Tat in transfected COS cells and HIV-1-infected lymphoid C8166 cells by means of ultrastructural in situ hybridization using antisense RNA probes and immunoelectron microscopy. The intranuclear viral RNA occurs in ribonucleoprotein fibrils in the perichromatin and interchromatin regions. The simultaneous demonstration of Rev, Tat, Br-labeled RNA, and cellular proteins SC35 and CRM1 in such fibrils reveals the potential of Rev to associate with nascent HIV pre-mRNA and its splicing complex and transport machinery. In a rev-minus system, the env intron-containing, incompletely spliced viral RNAs are revealed only in the nucleus, indicating that Rev is required to initiate the transport to the cytoplasm. Moreover, env intron sequences frequently occur in the periphery of interchromatin granule clusters, while the probe containing the rev exon sequence does not associate with this nucleoplasmic domain. When cells were treated with the CRM1 inhibitor leptomycin B in the presence of Rev protein, the env intron containing HIV RNAs formed clusters throughout the nucleoplasm and accumulated at the nuclear pores. This suggests that Rev is necessary and probably also sufficient for the accumulation of incompletely spliced HIV RNAs at the nuclear pores while CRM1 is needed for translocation across the nuclear pore complex.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12239324      PMCID: PMC136536          DOI: 10.1128/jvi.76.20.10473-10484.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

1.  Effect of Rev on the intranuclear localization of HIV-1 unspliced RNA.

Authors:  J P Favaro; K T Borg; S J Arrigo; M G Schmidt
Journal:  Virology       Date:  1998-09-30       Impact factor: 3.616

Review 2.  The HIV-1 Rev protein.

Authors:  V W Pollard; M H Malim
Journal:  Annu Rev Microbiol       Date:  1998       Impact factor: 15.500

Review 3.  Inhibition of the HIV Rev transactivator : a new target for therapeutic intervention.

Authors:  A Heguy
Journal:  Front Biosci       Date:  1997-06-01

4.  Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA.

Authors:  B Wolff; J J Sanglier; Y Wang
Journal:  Chem Biol       Date:  1997-02

Review 5.  Ultrastructure and morphogenesis of human immunodeficiency virus.

Authors:  M Nakai; T Goto
Journal:  J Electron Microsc (Tokyo)       Date:  1996-08

6.  Rev and the fate of pre-mRNA in the nucleus: implications for the regulation of RNA processing in eukaryotes.

Authors:  M H Malim; B R Cullen
Journal:  Mol Cell Biol       Date:  1993-10       Impact factor: 4.272

7.  Leptomycin B inactivates CRM1/exportin 1 by covalent modification at a cysteine residue in the central conserved region.

Authors:  N Kudo; N Matsumori; H Taoka; D Fujiwara; E P Schreiner; B Wolff; M Yoshida; S Horinouchi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-03       Impact factor: 11.205

8.  cis-acting elements in human immunodeficiency virus type 1 RNAs direct viral transcripts to distinct intranuclear locations.

Authors:  E Berthold; F Maldarelli
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

9.  A role for nucleoporin FG repeat domains in export of human immunodeficiency virus type 1 Rev protein and RNA from the nucleus.

Authors:  F Stutz; E Izaurralde; I W Mattaj; M Rosbash
Journal:  Mol Cell Biol       Date:  1996-12       Impact factor: 4.272

10.  Localization of HIV-1 RNA in mammalian nuclei.

Authors:  G Zhang; M L Zapp; G Yan; M R Green
Journal:  J Cell Biol       Date:  1996-10       Impact factor: 10.539

View more
  8 in total

1.  The functional architecture of the nucleus as analysed by ultrastructural cytochemistry.

Authors:  Stanislav Fakan
Journal:  Histochem Cell Biol       Date:  2004-08-05       Impact factor: 4.304

2.  Nuclear localization of the mitochondrial ncRNAs in normal and cancer cells.

Authors:  Eduardo Landerer; Jaime Villegas; Veronica A Burzio; Luciana Oliveira; Claudio Villota; Constanza Lopez; Franko Restovic; Ronny Martinez; Octavio Castillo; Luis O Burzio
Journal:  Cell Oncol (Dordr)       Date:  2011-02-24       Impact factor: 6.730

3.  ISH-IEM: a sensitive method to detect endogenous mRNAs at the ultrastructural level.

Authors:  Bram Herpers; Despina Xanthakis; Catherine Rabouille
Journal:  Nat Protoc       Date:  2010-03-18       Impact factor: 13.491

4.  SIVsm Tat, Rev, and Nef1: functional characteristics of r-GV internalization on isotypes, cytokines, and intracellular degradation.

Authors:  Marinko Sremac; Elizabeth S Stuart
Journal:  BMC Biotechnol       Date:  2010-07-19       Impact factor: 2.563

5.  Chimeric RNase H-competent oligonucleotides directed to the HIV-1 Rev response element.

Authors:  Chrissy E Prater; Anthony D Saleh; Maggie P Wear; Paul S Miller
Journal:  Bioorg Med Chem       Date:  2007-06-02       Impact factor: 3.641

6.  Detection of viral RNA by fluorescence in situ hybridization (FISH).

Authors:  Kishanda Vyboh; Lara Ajamian; Andrew J Mouland
Journal:  J Vis Exp       Date:  2012-05-05       Impact factor: 1.355

7.  Synonymous site conservation in the HIV-1 genome.

Authors:  Itay Mayrose; Adi Stern; Ela O Burdelova; Yosef Sabo; Nihay Laham-Karam; Rachel Zamostiano; Eran Bacharach; Tal Pupko
Journal:  BMC Evol Biol       Date:  2013-08-04       Impact factor: 3.260

8.  The myxobacterial metabolite ratjadone A inhibits HIV infection by blocking the Rev/CRM1-mediated nuclear export pathway.

Authors:  Eric Fleta-Soriano; Javier P Martinez; Bettina Hinkelmann; Klaus Gerth; Peter Washausen; Juana Diez; Ronald Frank; Florenz Sasse; Andreas Meyerhans
Journal:  Microb Cell Fact       Date:  2014-01-29       Impact factor: 5.328

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.